BACKGROUND AND PURPOSE: Report on the status of an on-going National Institutes of Neurological Disorders and Stroke (NINDS)-supported clinical trial of management of unbled brain arteriovenous malformations. SUMMARY OF REVIEW: Begun in April 2007 with 3 centers, the trial has grown to 65 centers, and has randomized 124 patients through mid-June 2010 en route to the planned 400. The current literature continues to support the rationale for the trial. CONCLUSIONS: ARUBA is steadily approaching its monthly randomization goals and has already reached the number needed to test the maximum published interventional complication rates against the minimum hemorrhage rates for natural history.
RCT Entities:
BACKGROUND AND PURPOSE: Report on the status of an on-going National Institutes of Neurological Disorders and Stroke (NINDS)-supported clinical trial of management of unbled brain arteriovenous malformations. SUMMARY OF REVIEW: Begun in April 2007 with 3 centers, the trial has grown to 65 centers, and has randomized 124 patients through mid-June 2010 en route to the planned 400. The current literature continues to support the rationale for the trial. CONCLUSIONS:ARUBA is steadily approaching its monthly randomization goals and has already reached the number needed to test the maximum published interventional complication rates against the minimum hemorrhage rates for natural history.
Authors: C Hofmeister; C Stapf; A Hartmann; R R Sciacca; U Mansmann; K terBrugge; P Lasjaunias; J P Mohr; H Mast; J Meisel Journal: Stroke Date: 2000-06 Impact factor: 7.914
Authors: Christian Stapf; Daniel L Labovitz; Robert R Sciacca; Henning Mast; Jay P Mohr; Ralph L Sacco Journal: Cerebrovasc Dis Date: 2002 Impact factor: 2.762
Authors: M F Berman; A Hartmann; H Mast; R R Sciacca; J P Mohr; J Pile-Spellman; W L Young Journal: AJNR Am J Neuroradiol Date: 1999 Nov-Dec Impact factor: 3.825
Authors: J P Mohr; J L Thompson; R M Lazar; B Levin; R L Sacco; K L Furie; J P Kistler; G W Albers; L C Pettigrew; H P Adams; C M Jackson; P Pullicino Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: R M Lazar; R S Marshall; J Pile-Spellman; H C Duong; J P Mohr; W L Young; R L Solomon; G M Perera; R L DeLaPaz Journal: Neuropsychologia Date: 2000 Impact factor: 3.139
Authors: P M Rothwell; M Eliasziw; S A Gutnikov; A J Fox; D W Taylor; M R Mayberg; C P Warlow; H J M Barnett Journal: Lancet Date: 2003-01-11 Impact factor: 79.321
Authors: C Stapf; H Mast; R R Sciacca; A Berenstein; P K Nelson; Y P Gobin; J Pile-Spellman; J P Mohr Journal: Stroke Date: 2003-04-10 Impact factor: 7.914
Authors: L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco Journal: Eur Radiol Date: 2013-05-08 Impact factor: 5.315
Authors: Brad E Zacharia; Kerry A Vaughan; Adam Jacoby; Zachary L Hickman; Daniel Bodmer; E Sander Connolly Journal: Curr Atheroscler Rep Date: 2012-08 Impact factor: 5.113
Authors: W Chang; M W Loecher; Y Wu; D B Niemann; B Ciske; B Aagaard-Kienitz; S Kecskemeti; K M Johnson; O Wieben; C Mistretta; P Turski Journal: AJNR Am J Neuroradiol Date: 2012-04-12 Impact factor: 3.825
Authors: Matthew B Potts; Darryl Lau; Adib A Abla; Helen Kim; William L Young; Michael T Lawton Journal: J Neurosurg Date: 2015-02-06 Impact factor: 5.115